Baxter International

Baxter International is a global, pharmaceutical and biotechnology company headquarted in Deerfield, Illinois. The company manufactures a wide variety of medical products divided into three divisions, across its three divisions, drugs and vaccines; dialysis equipment and IV supplies.

In the fiscal year ending in December of 2009, the company reported sales of approximately $12.56 billion dollars and had 49,700 employees.

Ties to the American Legislative Exchange Council
Baxter International has been a corporate funder of the American Legislative Exchange Council (ALEC). It was listed as a "Director" level sponsor of the 1998 ALEC Annual Conference, but not listed as a "Private Sector Member". See ALEC Corporations for more.

Animal testing
Baxter Healthcare does animal testing.

Facility information, progress reports & USDA-APHIS reports
For links to copies of a facility's U.S. Department of Agriculture (USDA)-Animal Plant Health Inspection (APHIS) reports, other information and links, see also Research Facilities: Baxter Healthcare Corporation, Round Lake, IL.

USDA AWA reports
As of May 26, 2009, the USDA began posting all inspection reports for animal breeders, dealers, exhibitors, handlers, research facilities and animal carriers by state. See also USDA Animal Welfare Inspection Reports.

Contract testing
Baxter contract tests out to Huntingdon Life Sciences (HLS). Huntingdon Life Sciences is the 3rd largest contract research organization (CRO) in the world and the largest animal testing facility in all of Europe. Firms hire CROs to conduct animal toxicity tests for agrochemicals, petrochemicals, household products, pharmaceutical drugs and toxins. HLS has a long history of gross animal welfare violations. See also Huntingdon Life Sciences.

Funding Patient Groups
In 2006, ECB contributed CHF 30,000 to the European Patients' Forum, a group overwhelmingly funded by the drug industry. One of its priority activities has been to support proposals to overturn the European Union ban on direct-to-consumer advertising. (See Direct-to-consumer advertising: The Campaign To Overturn Europe's Ban for the details of the history of the debate in Europe).

Political contributions
Baxter gave $251,479 to federal candidates in the 2008 election cycle through its political action committee (PAC); 46% to Democrats and 54% to Republicans.

Lobbying
The company spent $4,050,000 for lobbying in 2009. $680,000 went to four outside firms and the rest was spent on in-house lobbying.

Board members

 * Walter E. Boomer
 * Blake E. Devitt
 * John D. Forsyth
 * Gail D. Fosler
 * James R. Gavin III, M.D., Ph.D.
 * Peter S. Hellman
 * Wayne T. Hockmeyer, Ph.D.
 * Joseph B. Martin, M.D., Ph.D.
 * Robert L. Parkinson, Jr.
 * Carole J. Shapazian
 * Thomas T. Stallkamp
 * Kees J. Storm
 * Albert P.L. Stroucken

Executive officers

 * Joy A. Amundson
 * Peter J. Arduini
 * Robert M. Davis
 * J. Michael Gatling
 * Jeanne K. Mason
 * Bruce McGillivray
 * Robert L. Parkinson, Jr.
 * Norbert G. Riedel
 * David P. Scharf
 * Karenann Terrell
 * Cheryl L. White

Corporate officers

 * Carlos Alonso
 * Michael J. Baughman
 * Robert J. Hombach
 * Mary Kay Ladone
 * Gerald Lema
 * Peter Nicklin
 * Stephanie A. Shinn

Contact
Baxter International One Baxter Parkway Deerfield, IL 60015-4625

Phone: 847-948-2000

Web address: http://www.baxter.com/

SourceWatch articles

 * Animal testing
 * Biotechnology
 * Huntingdon Life Sciences
 * Pharmaceutical industry
 * Direct-to-consumer advertising
 * Direct-to-consumer advertising: The Campaign To Overturn Europe's Ban
 * Patient Groups/Europe
 * Louise Makin